# A Phase 1 SAD/MAD Study of RLS-0071 in Healthy Volunteers in Support of a COVID-19 Development Program

> **NCT05298787** · PHASE1 · COMPLETED · sponsor: **ReAlta Life Sciences, Inc.** · enrollment: 56 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** RLS-0071
- **DRUG:** Saline Placebo

## Key facts

- **NCT ID:** NCT05298787
- **Lead sponsor:** ReAlta Life Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-13
- **Primary completion:** 2021-08-16
- **Final completion:** 2021-08-16
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2022-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05298787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05298787, "A Phase 1 SAD/MAD Study of RLS-0071 in Healthy Volunteers in Support of a COVID-19 Development Program". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05298787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*